Our data demonstrate that our Bifidobacterium and Lactobacillus strains are effective in inducing immunological tolerance to AChR and myelin basic protein (MBP), the target antigens in MG and MS; further studies need to be performed to evaluate the use of probiotics as a potential therapeutic approach for these autoimmune diseases. The gene discussed is MBP; the disease is autoimmune disease.